StartX provides access to talent and resources as Avenue Biosciences grows presence in the North American biotechnology market.

StartX is a Silicon Valley-based community for Stanford students, professors and alumni. It is known as a launchpad for some of the most innovative growth companies in the world. With over 1,600 founders, this network includes 165 companies valued at over $100 million, including 18 unicorns.

“Avenue Biosciences is building synthetic biologics tools that will reduce the time and cost of bringing life-saving therapies to market. I am honored that we were chosen to be part of this network that fosters lifelong support and collaboration for entrepreneurs”, comments Avenue Biosciences CEO and co-founder Tero-Pekka Alastalo.

Alastalo did his postdoctoral training at Stanford University School of Medicine on the molecular genetic mechanisms of cardiovascular diseases.  

StartX supports companies in all areas of the industry, and provides specific resources and expertise across medicine, artificial intelligence and sustainability.

“We are creating new machine learning tools and industry-first datasets that offer insights into optimizing protein biogenesis. With an impressive business exposure in artificial intelligence, StartX can accelerate our efforts in this area”, Alastalo continues.

Further information:

CEO Tero-Pekka Alastalo, tpa@avenuebiosciences.com
Communications: Juulia Simonen, juulia.simonen@avenuebiosciences.com, +358503059018

About Avenue Biosciences

Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers.  

Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biologics and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. www.avenuebiosciences.com